Role of inflammation and its treatment in esrd patients

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

As renal function declines, the prevalence of both malnutrition and cardiovascular disease increase. Both malnutrition and vascular disease correlate with the levels of markers of inflammation both in patients treated with dialysis and in those not yet on dialysis. While it is possible that the markers of inflammation (increased levels of C-reactive protein (CRP) or interleukin-6 (IL-6)) are a result of inflammation arising from the atherosclerotic process, changes in endothelial cell gene expression, in plasma protein composition and in lipoprotein structure that arise from inflammation are likely to be atherogenic. The causes of inflammation are likely to be multifactorial. CRP levels are associated with cardiovascular risk in the general population and decrease following treatment with HMG-CoA reductase inhibitors. It is speculated that use of these agents or directly suppressing inflammation may have use in treating the inflammatory-malnutrition syndrome in dialysis patients.

Original languageEnglish (US)
Pages (from-to)70-80
Number of pages11
JournalBlood Purification
Volume20
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Inflammation
Malnutrition
Dialysis
C-Reactive Protein
Therapeutics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Population Dynamics
Vascular Diseases
Lipoproteins
Blood Proteins
Interleukin-6
Cardiovascular Diseases
Endothelial Cells
Kidney
Gene Expression

Keywords

  • Albumin
  • C-reactive protein
  • Cytokines
  • Inflammation
  • Interleukin-6
  • Nutrition
  • Prealbumin

ASJC Scopus subject areas

  • Nephrology
  • Hematology

Cite this

Role of inflammation and its treatment in esrd patients. / Kaysen, George.

In: Blood Purification, Vol. 20, No. 1, 2002, p. 70-80.

Research output: Contribution to journalArticle

@article{d15169fc928a4655b86eec333f59ece4,
title = "Role of inflammation and its treatment in esrd patients",
abstract = "As renal function declines, the prevalence of both malnutrition and cardiovascular disease increase. Both malnutrition and vascular disease correlate with the levels of markers of inflammation both in patients treated with dialysis and in those not yet on dialysis. While it is possible that the markers of inflammation (increased levels of C-reactive protein (CRP) or interleukin-6 (IL-6)) are a result of inflammation arising from the atherosclerotic process, changes in endothelial cell gene expression, in plasma protein composition and in lipoprotein structure that arise from inflammation are likely to be atherogenic. The causes of inflammation are likely to be multifactorial. CRP levels are associated with cardiovascular risk in the general population and decrease following treatment with HMG-CoA reductase inhibitors. It is speculated that use of these agents or directly suppressing inflammation may have use in treating the inflammatory-malnutrition syndrome in dialysis patients.",
keywords = "Albumin, C-reactive protein, Cytokines, Inflammation, Interleukin-6, Nutrition, Prealbumin",
author = "George Kaysen",
year = "2002",
doi = "10.1159/000046988",
language = "English (US)",
volume = "20",
pages = "70--80",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Role of inflammation and its treatment in esrd patients

AU - Kaysen, George

PY - 2002

Y1 - 2002

N2 - As renal function declines, the prevalence of both malnutrition and cardiovascular disease increase. Both malnutrition and vascular disease correlate with the levels of markers of inflammation both in patients treated with dialysis and in those not yet on dialysis. While it is possible that the markers of inflammation (increased levels of C-reactive protein (CRP) or interleukin-6 (IL-6)) are a result of inflammation arising from the atherosclerotic process, changes in endothelial cell gene expression, in plasma protein composition and in lipoprotein structure that arise from inflammation are likely to be atherogenic. The causes of inflammation are likely to be multifactorial. CRP levels are associated with cardiovascular risk in the general population and decrease following treatment with HMG-CoA reductase inhibitors. It is speculated that use of these agents or directly suppressing inflammation may have use in treating the inflammatory-malnutrition syndrome in dialysis patients.

AB - As renal function declines, the prevalence of both malnutrition and cardiovascular disease increase. Both malnutrition and vascular disease correlate with the levels of markers of inflammation both in patients treated with dialysis and in those not yet on dialysis. While it is possible that the markers of inflammation (increased levels of C-reactive protein (CRP) or interleukin-6 (IL-6)) are a result of inflammation arising from the atherosclerotic process, changes in endothelial cell gene expression, in plasma protein composition and in lipoprotein structure that arise from inflammation are likely to be atherogenic. The causes of inflammation are likely to be multifactorial. CRP levels are associated with cardiovascular risk in the general population and decrease following treatment with HMG-CoA reductase inhibitors. It is speculated that use of these agents or directly suppressing inflammation may have use in treating the inflammatory-malnutrition syndrome in dialysis patients.

KW - Albumin

KW - C-reactive protein

KW - Cytokines

KW - Inflammation

KW - Interleukin-6

KW - Nutrition

KW - Prealbumin

UR - http://www.scopus.com/inward/record.url?scp=0036007326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036007326&partnerID=8YFLogxK

U2 - 10.1159/000046988

DO - 10.1159/000046988

M3 - Article

C2 - 11803162

AN - SCOPUS:0036007326

VL - 20

SP - 70

EP - 80

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 1

ER -